Aratana Therapeutics is a pet therapeutics company focused on licensing, developing, and commercializing innovative therapeutics for dogs and cats. Its goal is to provide veterinarians and pet owners with new therapeutics that are driven by science and specifically made for pets. Its pipeline includes therapeutic candidates for the potential treatment of pain, inappetence, viral diseases, allergy, cancer, and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets.